UnitedHealth Depreciation And Amortization from 2010 to 2025

UNH Stock  USD 542.49  0.00  0.00%   
UnitedHealth Group's Depreciation And Amortization is increasing with slightly volatile movements from year to year. Depreciation And Amortization is estimated to finish at about 4.3 B this year. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
1989-06-30
Previous Quarter
B
Current Value
B
Quarterly Volatility
301.9 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check UnitedHealth Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UnitedHealth Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 B, Total Revenue of 420.3 B or Gross Profit of 93.9 B, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0168 or PTB Ratio of 3.19. UnitedHealth financial statements analysis is a perfect complement when working with UnitedHealth Group Valuation or Volatility modules.
  
Check out the analysis of UnitedHealth Group Correlation against competitors.

Latest UnitedHealth Group's Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of UnitedHealth Group Incorporated over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. UnitedHealth Group's Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UnitedHealth Group's overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

UnitedHealth Depreciation And Amortization Regression Statistics

Arithmetic Mean2,387,346,875
Geometric Mean1,479,570,144
Coefficient Of Variation50.65
Mean Deviation977,271,875
Median2,428,000,000
Standard Deviation1,209,217,668
Sample Variance1462207.4T
Range4.3B
R-Value0.99
Mean Square Error43946T
R-Squared0.97
Slope250,398,897
Total Sum of Squares21933110.5T

UnitedHealth Depreciation And Amortization History

20254.3 B
20244.1 B
2023B
20223.4 B
20213.1 B
20202.9 B
20192.7 B

About UnitedHealth Group Financial Statements

Investors use fundamental indicators, such as UnitedHealth Group's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although UnitedHealth Group's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Depreciation And Amortization4.1 B4.3 B

Currently Active Assets on Macroaxis

When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.043
Earnings Share
15.49
Revenue Per Share
427.221
Quarterly Revenue Growth
0.092
Return On Assets
0.0692
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.